Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC)
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Triple Negative
Interventions: DRUG: Temozolomide|DRUG: Olaparib
Sponsor: AHS Cancer Control Alberta